Documentation scienceplus.abes.fr version Bêta

À propos de : Critical study of 5% guanethidine in ocular manifestations of Graves's disease        

AttributsValeurs
type
Is Part Of
Subject
Title
  • Critical study of 5% guanethidine in ocular manifestations of Graves's disease
has manifestation of work
related by
Abstract
  • Assessment was made of 5% local guanethidine in treating eye manifestations in euthyroid patients with either treated thyrotoxicosis or ophthalmic Graves's disease. In a double-blind crossover study guanethidine caused greater improvement in lid retraction than a control solution. A long-term study showed that this improvement was maintained. A much lower incidence of side-effects was noted with 5% guanethidine than with 10% solution.
article type
is part of this journal
PubMed ID
  • 4902494



Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata